3-(Tetrazol-5-yl), 4-methyl-8-alkoxy coumarins and anti-allergic compositions thereof
AssigneeKakenyaku Kako Co., Ltd.
InventorsKiyoshi Kuriyama, Jun Nakano, Kiyonosin Itikawa, Kiyoshi Ito, Yuji Suzuki, Katsuro Ishizuki
Life of this patent
Estimating the term…
Abstract
Coumarin derivatives of the general formula: ##STR1## wherein R is hydrogen atom, an alkyl group or an alkenyl group, R.sup.1 is hydrogen atom, an alkyl group, an alkenyl group or an alkoxy group, and the OR and R.sup.1 groups each are substituted at any of the 5, 6, 7 and 8 positions of the coumarin ring, and the salt thereof. The compounds are useful as antiallergic agent for preventing and treating allergic diseases.
Claims6
A coumarin derivative of the formula:
- ##STR10## wherein R is a normal pentyl group, a normal hexyl group, and a normal heptyl group, the OR group being positioned on the 8 position of the coumarin ring, and wherein R.sup.1 is hydrogen or methyl, said R.sup.1 being positioned on the 6 position of the coumarin ring.
8-n-hexyloxy-3-(1H-tetrazol-5-yl)coumarin.
8-n-hexyloxy-3-(1H-tetrazol-5-yl)coumarin.
8-n-heptyloxy-3-(1H-tetrazol-5-yl)coumarin.
A pharmaceutical composition having an anti-allergic activity which comprises, as the essential active ingredient, an effective amount of a coumarin derivative of the following general formula:
- ##STR11## wherein R is a normal pentyl group, a normal hexyl group, and a normal heptyl group, the OR group being positioned on the 8 position of the coumarin ring, and wherein R.sup.1 is hydrogen or methyl, said R.sup.1 being positioned on the 6 position of the coumarin ring, or a pharmaceutically acceptable salt of said coumarin derivative and a pharmaceutically acceptable carrier.
A pharmaceutical composition having an anti-allergic activity which comprises, as the essential active ingredient, an effective amount of a coumarin derivative selected from the group consisting of 8-n-pentyloxy-3-(1H-tetrazol-5-yl)-coumarin, 8-n-hexyloxy-3-(1H-tetrazol-5-yl)-coumarin, and 8-n-heptyloxy-3-(1H-tetrazol-5-yl)-coumarin or a pharmaceutically acceptable salt of said coumarin derivative and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.